Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-10-29
|
pubmed:abstractText |
The involvement of nitrergic mechanisms in the behavioural effects of diazepam in rats was studied in the elevated plus-maze, open-field and rotarod tests. Administration of the nitric oxide (NO) precursor L-arginine (100 mg/kg, i.p.), assumed to increase the synthesis of NO, abolished the anxiolytic-like effect of diazepam (2 mg/kg, i.p.) in the elevated plus-maze, whereas the inactive enantiomer D-arginine (100 mg/kg) did not. Neither diazepam alone nor in combination with L- or D-arginine affected the exploratory activity of animals in the open field. Pretreatment with L-arginine (100 and 200 mg/kg) did not modify the motor impairment of rats after diazepam (3 mg/kg) in the rotarod test. Diazepam (2 mg/kg i.p.) did not inhibit the cortical or hippocampal cytosolic NO synthase activity measured ex vivo by [3H]L-arginine assay. Diazepam was similarly ineffective in in vitro studies at concentrations up to 10 microM. We conclude that a suppression of NO synthase activity may be important in the anxiolytic-like effect of benzodiazepines. However, diazepam does not inhibit NO synthase directly, but may affect NO synthase activity indirectly via some unknown mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Anxiety Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Diazepam,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
351
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
287-90
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9721019-Animals,
pubmed-meshheading:9721019-Anti-Anxiety Agents,
pubmed-meshheading:9721019-Arginine,
pubmed-meshheading:9721019-Diazepam,
pubmed-meshheading:9721019-Frontal Lobe,
pubmed-meshheading:9721019-GABA-A Receptor Agonists,
pubmed-meshheading:9721019-Hippocampus,
pubmed-meshheading:9721019-Male,
pubmed-meshheading:9721019-Maze Learning,
pubmed-meshheading:9721019-Motor Activity,
pubmed-meshheading:9721019-Nitric Oxide,
pubmed-meshheading:9721019-Nitric Oxide Synthase,
pubmed-meshheading:9721019-Rats,
pubmed-meshheading:9721019-Rats, Wistar
|
pubmed:year |
1998
|
pubmed:articleTitle |
L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats.
|
pubmed:affiliation |
Department of Physiology, University of Tartu, Estonia. vallov@ut.ee
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|